Article
The R263K substitution in HIV-1 subtype C is more deleterious for integrase enzymatic function and viral replication than in subtype B.
AIDS (London, England) - 31 Jul 2015
Mesplède Thibault, Quashie Peter K, Hassounah Said, Osman Nathan, Han Yingshan, Liang Jiaming, Singhroy Diane N, Wainberg Mark A
Abstract excerpt
OBJECTIVES: Dolutegravir is an integrase strand-transfer inhibitor that has shown unprecedented robustness against the emergence of HIV drug-resistant strains in treatment-naive individuals. The R263K substitution in integrase was identified through culture selection as a resistance-associated substitution for dolutegravir and was recently detected in two treatment-experienced participants in the SAILING clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
